Table 4 Cumulative incidence of influenza vaccine uptake by season between July 2015 and February 2020 among patients with systemic lupus erythematosus (SLE) and matched comparators in the Lupus Midwest Network cohort
Cumulative incidence, % (95% CI) | |||
|---|---|---|---|
Influenza season | SLE | Non-SLE | HRa (95% CI) |
2015–2016 | 61.0 (56.6–65.8) | 52.5 (48.0–57.5) | 1.34 (1.12–1.60) |
2016–2017 | 62.8 (58.4–67.7) | 52.6 (48.0–57.6) | 1.35 (1.13–1.62) |
2017–2018 | 59.4 (54.8–64.5) | 51.2 (46.5–56.4) | 1.30 (1.08–1.57) |
2018–2019 | 59.7 (54.9–64.9) | 55.4 (50.6–60.7) | 1.25 (1.03–1.51) |
2019–2020b | 63.0 (58.1–68.3) | 61.5 (56.4–66.9) | 1.14 (0.94–1.38) |